JP2024511066A5 - - Google Patents

Info

Publication number
JP2024511066A5
JP2024511066A5 JP2023557667A JP2023557667A JP2024511066A5 JP 2024511066 A5 JP2024511066 A5 JP 2024511066A5 JP 2023557667 A JP2023557667 A JP 2023557667A JP 2023557667 A JP2023557667 A JP 2023557667A JP 2024511066 A5 JP2024511066 A5 JP 2024511066A5
Authority
JP
Japan
Prior art keywords
crfr2
maladjustment
composition according
agonist
ct38s
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023557667A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024511066A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/071209 external-priority patent/WO2022198230A1/en
Publication of JP2024511066A publication Critical patent/JP2024511066A/ja
Publication of JP2024511066A5 publication Critical patent/JP2024511066A5/ja
Pending legal-status Critical Current

Links

JP2023557667A 2021-03-17 2022-03-17 不適応ストレス応答から生じる疾患を治療する改善された方法 Pending JP2024511066A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163200609P 2021-03-17 2021-03-17
US63/200,609 2021-03-17
PCT/US2022/071209 WO2022198230A1 (en) 2021-03-17 2022-03-17 Improved methods of treating diseases resulting from a maladapted stress response

Publications (2)

Publication Number Publication Date
JP2024511066A JP2024511066A (ja) 2024-03-12
JP2024511066A5 true JP2024511066A5 (https=) 2025-03-26

Family

ID=83320930

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023557667A Pending JP2024511066A (ja) 2021-03-17 2022-03-17 不適応ストレス応答から生じる疾患を治療する改善された方法

Country Status (6)

Country Link
US (1) US20250319161A1 (https=)
EP (1) EP4308150A4 (https=)
JP (1) JP2024511066A (https=)
AU (1) AU2022238570A1 (https=)
CA (1) CA3212248A1 (https=)
WO (1) WO2022198230A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117618528B (zh) * 2023-12-01 2024-10-01 广东医科大学 一种方格星虫多肽srp及其在制备治疗急性肾损伤药物中的应用
TW202544027A (zh) * 2024-04-19 2025-11-16 美商紐羅克里生物科學有限公司 促皮質素釋放因子受體２（ｃｒｆｒ２）促效劑

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110105397A1 (en) * 2009-11-04 2011-05-05 Gengo Peter J Method for treating heart failure with stresscopin-like peptides
KR20190084055A (ko) * 2016-10-20 2019-07-15 코르텐 인코포레이티드 부적응 스트레스 반응에서 기인한 질환의 치료 방법

Similar Documents

Publication Publication Date Title
US11759506B2 (en) AADC polynucleotides for the treatment of Parkinson's disease
TWI725973B (zh) 抗-ｃｇｒｐ抗體調配物
JP2022501040A5 (https=)
JP2024511066A5 (https=)
US20160361436A1 (en) Antibody conjugates and methods of making the antibody conjugates
JP2004536103A5 (https=)
JP2008525477A5 (https=)
JP2015520128A (ja) 長時間作用性オキシントモジュリン変異体とその作製方法
JP2005525404A (ja) Ｈｉｖ感染およびａｉｄｓを処置するためにサイトカインアンタゴニストを使用する方法
US20190309021A1 (en) Composition Comprising a Peptide and an Inhibitor of Viral Neuraminidase
EP3937944B1 (en) Toll-like receptor agonists for use in the treatment of hepatitis b
US20160017333A1 (en) Dna aptamers for promoting remyelination
JP2020535161A5 (https=)
JP2022533981A5 (https=)
JP2020514305A5 (https=)
JP2023533162A5 (https=)
WO2021007382A1 (en) Compositions and methods for the treatment of parkinson's disease
JP2003528138A5 (https=)
US20060069104A1 (en) Neurotrophic factor production accelerator
JP2022550954A5 (https=)
JP2021102624A (ja) Ｃｙｒ６１及びｖｅｇｆ媒介性の状態の治療
WO2006077824A1 (ja) 神経細胞再生のための医薬
RU2721282C2 (ru) Способ лечения рассеянного склероза (варианты)
JP2014505074A5 (https=)
JP7850669B2 (ja) Ｓ１ｐ受容体調節物質